EP1057732A1 - Container for medical and fine-chemical use - Google Patents

Abstract

A container comprising an internal diameter that tapers over its entire height, or over the lower section down to the base, is new. The base is indented (4) to a degree described by a ratio expressed as the percentage of the internal radius of the container represented by indentation height. The percentage exceeds 10%, or preferably 18%. A container comprising an internal diameter which has a conical taper. The relative container base taper is expressed as the difference of maximum and minimum casing radii to height of tapering and exceeds 5%, preferably 18%. The relative base indentation exceeds 25% of the inner base radius. It is less than 80%, preferably less than 50%. The radially-outer container base has a flattened annular region with inner to outer radius ratio of 40%-80%. The internal base indentation (4) is formed conically up to the casing (1). Its height is 11-150 mm, with a wall thickness at the casing of 0.2 mm to 3 mm. An Independent claim is also included for a polygonal variant.

Description

• einem dünnwandigen transparenten Behältermantel,
• einem daran angeformten Ausflußteil, das mit einem üblichen Verschluß verschließbar ist, und
• einem Boden, der mit einem zentrischen Einzug versehen ist.

The invention relates to a container for medical and fine chemical purposes for liquid and solid preparations, with

• a thin-walled transparent container jacket,
• an integrally formed discharge part, which can be closed with a conventional closure, and
• a floor with a central indentation.

The invention is particularly applicable to in-situ production and Storage of freeze-dried medical and biological Products as well as fine chemicals. Using this application existing problems shall be the background of the invention in the following are presented without the invention being restricted thereto.

Special medical including biological products, pharmaceuticals like Diagnostics, as well as fine chemicals that are manufactured or applied as a solution are, but are not stable in the solvent, come out, in particular Long-term pharmaceutical stability as freeze-dried Products in containers, such as vials, vials or ampoules on the market. Freeze drying, lyophilization, is typically carried out in such a way that the liquid to be lyophilized in the container itself Freeze drying process (freezing of the container contents with sublimation of the Solvent by pumping) is subjected, the container before the filling is washed and sterilized. After freeze drying the containers are closed with an elastomer plug, and after further procedural steps are sent. Immediately before The lyophilized substance is applied to the consumer by filling dissolved in a liquid and typically into a needle Disposable syringe added. As a result, the container content is only for a short time in solution.

a) mechanische Festigkeit
Die Behälter müssen nicht nur eine ausreichende Festigkeit bei Lagerung und Transport aufweisen, sondern auch den mechanischen Belastungen beim Einfrieren, insbesondere bedingt durch die flüssigfest-Dichteanomalie von wässrigen Lösungen (der Wasser-Eis-Phasenübergang ist mit einer Volumenzunähme von ca. 11 % verbunden) und beim Verschließen, z.B. durch Zuschmelzen, widerstehen.

b) gute Wärmeleitfähigkeit
Im Hinblick auf eine hohe Produktionsrate und um Energie zu sparen, muß der Behälter ein schnelles Einfrieren der Lösung im Behälter ermöglichen.

c) hohe chemische Inertheit
Um unerwünschte Reaktionen mit dem Behälterinhalt zu vermeiden, darf die Behälterinnenfläche nicht mit dem Behälterinhalt chemisch reagieren oder darf nicht auslaugen. Der Behälter muß daher als pharmazeutisches Verpackungsmittel zugelassen sein.

d) Sterilierbarkeit
Die Behälter müssen mit den üblichen Methoden, an die gerade im Pharmabereich hohe Anforderungen gestellt werden, sterilisierbar sein.

e) Transparenz
Um eine visuelle Inspektion des Behälterinhaltes zu ermöglichen, muß die Behälterwand eine ausreichende Transparenz aufweisen. Insbesondere muß die gefriergetrocknete Substanz beim Auflösen unmittelbar vor ihrer bestimmungsgemäßen Verwendung einer Begutachtung, z.B. durch medizinisches Personal, zugänglich sein.

f) Dichtheit
Um eine Langzeitlagerung zu gewährleisten, müssen die Behälter permeationsdicht sein.

Containers used for freeze-drying the aforementioned products must have different properties. These include in particular:

a) mechanical strength
The containers not only have to have sufficient strength during storage and transport, but also the mechanical loads during freezing, in particular due to the liquid-solid density anomaly of aqueous solutions (the water-ice phase transition is associated with an increase in volume of approx. 11%) and resist when closing, e.g. by melting.

b) good thermal conductivity
In view of a high production rate and to save energy, the container must allow the solution in the container to freeze quickly.

c) high chemical inertness
In order to avoid undesirable reactions with the contents of the container, the inner surface of the container must not react chemically with the contents of the container or leach out. The container must therefore be approved as a pharmaceutical packaging.

d) sterilizability
The containers must be sterilizable using the usual methods, which are particularly demanding in the pharmaceutical sector.

e) transparency
In order to enable a visual inspection of the contents of the container, the container wall must have sufficient transparency. In particular, the freeze-dried substance must be accessible for inspection, for example by medical personnel, when it is dissolved immediately before its intended use.

f) tightness
To ensure long-term storage, the containers must be permeation-proof.

It is known (JP 27 67 016), vials for freeze-dried substances made of stainless steel or aluminum. These have a high one mechanical strength, are good heat conductors and well sterilizable, as well have the required tightness. Their disadvantages are the high price lack of transparency and lack of chemical inertness.

Because of the above disadvantages of metallic containers have therefore Glass containers prevailed on the market as lyophilization containers.

As a material for containers for freeze drying or for the storage of freeze-dried medical products, glass is also given priority over plastic, because in contrast to plastics, glass has extraordinarily high barrier values against water vapor, CO ₂ and oxygen, and is therefore for many medical, biological and fine chemical products can be used universally, while plastics have good barrier properties against either water vapor or oxygen and carbon dioxide, but not at the same time against water vapor and oxygen / carbon dioxide to a sufficient extent for numerous ingredients.

For special medical substances with low demands on the Protective effect of the container and / or short storage times are, however Plastic containers can be used in principle. So far, however, they are not widely used for parenteral preparations.

Glass containers for the aforementioned purposes are both as tubular glass containers also on the market as a cottage glass container, which is based on known processes getting produced.

To the tubular glass containers that are made from prefabricated glass tubes Forming and cutting are typically included Ampoules, vials, syringe barrels and syringe bodies, their shapes and typical dimensions in DIN ISO 9187 part 1 or DIN ISO 8362 part 1 or DIN ISO 13926 part 1 and DIN ISO 11040 part 2.

To the cottage glass containers made by molding a glass melt directly manufactured by blow or press blow molding processes include e.g. Injection and Infusion bottles, such as those in DIN ISO 8362 Part 4 or DIN ISO 8536 are described in more detail.

Glass containers for the aforementioned purposes have plastic containers also the advantage that they deal with recognized pharmaceutical procedures have sterilized, e.g. with hot air at temperatures of approx. 300 ° C. This is particularly the case if the containers are made of borosilicate glass, because borosilicate glass has a high thermal shock resistance, which also the lyophilization process with temperatures between minus 45 ° C and plus 30 ° C is important.

The glass containers for the aforementioned purposes therefore typically have one high transparency and tightness and are easy to sterilize, but they need Requirements for mechanical strength, good thermal conductivity and special attention to chemical inertness.

For example, DE 40 14 665 C1 describes freeze-drying vials made of glass have a silicone inner coating for chemical passivation.

In principle, however, the use of silicone oil is prohibited Surface modification of freeze drying containers as this too undesirable contamination of the lyophilisates after freeze-drying can lead. In addition, the use of silicone for parenteral Products are only used in absolute exceptional cases, because only in this way can be excluded that silicone droplets by injection into the Body can get. This also applies not only to freeze-dried Products, but for all injection / infusion preparations in liquid or solid form.

In addition, for reasons of rational Processing / use of the containers generally also for liquid and not only Freeze-dried medical preparations should be able to be used the storage of various containers to a minimum limit what is not necessary with a siliconized inner surface Scope is possible.

The necessary chemical inertness is therefore typically determined by the Use of inert special glasses for the production of the glass containers guaranteed.

An essential aspect of lyophilization is the rapid freezing during the freeze-drying process. Since glass has a relatively high thermal resistance, this prevents quick freezing.
To reduce the heat resistance, you can reduce the wall thickness of the vials. However, the mechanical strength suffers. In particular, this increases the risk of breakage in the lyophilization in a known manner, which has considerable disadvantages. In the event of a break, the pharmaceutical systems have to be cleaned very laboriously, which can lead to a considerable loss of production.

A compromise is therefore necessary. It turns out that at Glass vials with a wall thickness in the jacket and bottom area between 0.2 mm and 3 mm the thermal resistance is sufficiently low and the Fracture rate during storage, lyophilization and transport remains low.

It is common to cool the glass containers through their bases. One disadvantage is here that an ice plug can settle on the ground, which the Can blow up the glass container. The tensions in the container through Thermal gradients in the floor or jacket can also break to lead.

It has also been suggested that the risk of breakage by adding Additives, i.e. of small amounts of inorganic or organic Components, such as potassium chloride and lactose, to the contents of the container to reduce. However, such an approach is extremely rare acceptable because of the pharmaceutical formulation of the product must be changed to adapt to an unsuitable Reach container.

To the problems of cooling the contents of the container through the bottom of the container to escape and a quick freeze-drying process with low To achieve breakage rates is a device by DE-OS 20 45 382 became known, in which rotating vials on cooled walls of a inclined wearer. The heat is removed by the Vial coat. When sliding on the wall or on the support plate however, scratches may appear on the outside of the vial, which Reduce strength.

It is also known to use liquid refrigerant coupling agents (e.g. brine or glycol solutions) to use to increase the cooling rate. DE-OS 27 32 225 describes e.g. a procedure in which the vial lies in Rotate coolant. To do this, the vials must freeze closed and opened again for sublimation. This process can in turn be associated with a broken glass.

In addition to the risk of breakage during lyophilization, as in section a) described, also on sufficient mechanical strength when Close the container.

It is known, by suitable design of the opening area of Vial, use of appropriate caps and procedures, the breakage rate to reduce when closing. This is how DD 21 36 42 describes it Lyophilization vial with a conical opening area to hold one To be able to fit locking mechanism. EP 0 403 626 and EP 0 406 374 describe lyophilization vials with a valve-shaped one Opening.

Due to the older patent application 198 31 112.5-43 it also belongs to the stand the technology, the breakage rate of glass vials etc. through a special Formation of the bottom part to minimize. US 4,197,954 also shows Plastic lyophilizing vial with a bottom part that is centric Has indentation, but the indentation depth is so small that there is no risk of breakage is sufficiently diminished. Furthermore, this writing shows no one on the ground tapered coat of the vial.

The invention has for its object the container described above for medical and fine chemical purposes so in its geometry train that he has a low breakage rate during the freezing process owns.

• einem dünnwandigen transparenten Behältermantel,
• einem daran angeformten Ausflußteil, das mit einem üblichen Verschluß verschließbar ist, und
• einem Boden, der mit einem zentrischen Einzug versehen ist,

gekennzeichnet durch eine Verjüngung des Behälterinnendurchmessers über die gesamte Mantelhöhe oder des unteren Teiles davon zum Boden hin, und/oder durch einen relativen Bodeneinzug des Behälters, beschrieben durch das relative Verhältnis aus der Höhe des Bodeneinzuges zum Innenradius des Behälters, das mehr als 10 %, bevorzugt mehr als 18 % des Innenradius am Behälterboden beträgt.This object is achieved according to the invention by a container for medical and fine chemical purposes for liquid and solid preparations

• a thin-walled transparent container jacket,
• an integrally formed discharge part, which can be closed with a conventional closure, and
• a floor with a central indentation,

characterized by a tapering of the inside diameter of the container over the entire jacket height or the lower part thereof towards the bottom, and / or by a relative bottom indentation of the container, described by the relative ratio of the height of the bottom indentation to the inside radius of the container, which is more than 10%, is preferably more than 18% of the inner radius at the bottom of the container.

This measure can advantageously a favorable pressure distribution on the Walls of the container are achieved, which the fracture rate at Freezing process significantly reduced.

It has proven to be advantageous to limit the ground intake, such that the bottom of the container is less than 80% and preferably less than 50% of the inner radius at the bottom of the container.

To ensure the stability of the container and the thermal coupling in the According to one embodiment of the invention, increasing the floor area is the Container designed so that the bottom of the container radially on the outside flattened, annular region, in which the ratio of Inner radius to outer radius is at least 40% and at most 80%, preferably the inner surface of the floor feeder up to Container jacket is conically shaped.

The favorable pressure distribution can be according to a feature of the invention by tapering the inside diameter of the container over the entire length Improve the jacket height or the lower part of it towards the floor. The taper is advantageously conical, i.e. conical, whereby expediently the relative tapering of the container bottom, predetermined by the ratio of the difference from the largest to the smallest shell radius to the height the taper more than 5%, preferably more than Is 12% and most preferably more than 18%.

Further design features and advantages of the invention result based on the description of shown in the drawings Embodiments. In this description of rotationally symmetrical glass vials, because these are the have great importance and are made of inexpensive glass tubes with low Have manufacturing tolerances manufactured inexpensively. The invention can but can also be used for non-rotationally symmetrical vials, especially those with a polygonal base; these will therefore included in the invention.

Fig. 1

in einer Halb-Schnittdarstellung die Konfiguration des erfindungsgemäßen Behälters mit einem tiefen Bodeneinzug,

Fig. 2

eine Darstellung entsprechend Fig. 1, jedoch mit einem planen ringförmigen Bodenbereich am Rand des Bodens des Behälters,

Fig. 3

eine Darstellung gemäß Fig. 2 mit einem Fläschchen, bei dem der Innenbereich des eingezogenen Bodens auch im ringförmigen planen Bodenbereich konisch gestaltet ist,

Fig. 4

eine Darstellung entsprechend Fig. 1 mit einem Fläschchen, dessen Mantel sich über die gesamte Länge zum Boden hin verjüngt, und

Fig. 5

eine Darstellung entsprechend Fig. 4 mit einem Fläschchen, dessen Mantel sich nur im unteren Bereich zum Boden hin verjüngt.

Show it:

Fig. 1

in a half-sectional view the configuration of the container according to the invention with a deep bottom indentation,

Fig. 2

1, but with a flat annular bottom area at the edge of the bottom of the container,

Fig. 3

2 with a vial, in which the inner region of the retracted base is also conical in the annular, flat base region,

Fig. 4

a representation corresponding to FIG. 1 with a vial, the jacket tapers over the entire length to the bottom, and

Fig. 5

4 with a vial, the jacket of which tapers only towards the bottom in the lower region.

The container according to the invention for medical and fine chemical purposes is for liquid and solid preparations in all figures because of its rotationally symmetrical training only shown in half.

It has a thin-walled container jacket 1 of height H1, which at one Container height H1 from 11 mm to 150 mm with an outside diameter between 5 mm and 100 mm and a wall thickness in the range of 0.2 mm to 3 mm owns. The inside diameter is labeled R1.

On the container jacket 1 there is a tapered neck portion, i.e. an outflow part 2 molded on, which can be closed with a conventional closure, here by Flanging the edge bead 2 a with a lid. The container has one Bottom 3, which is provided with a deep central indentation 4.

In the description of the invention, it is assumed that the freeze-drying substance is in aqueous solution, that is Freezing process freezes the water to ice and a density anomaly (the Water is 11% denser than ice). The features of the invention however, they also have a positive effect on the lyophilization of other solutions.

Observations with stress optical methods, strain and Fracture analyzes have shown that the deep indentation 4 has a strong positive Influence the pressure distribution with which the ice plug Bottle wall 1 spanned during freeze-drying. The pressure on the floor 4 therefore decreases. In principle, this has a favorable influence on the Stress distribution in the vial, resulting in a lower breakage rate leads during freeze drying.

It has proven to be particularly favorable with regard to the reduction in the breakage rate if the relative bottom draw-in, ie the relative ratio of the height of the bottom _draw-in h ₁ to the inner radius of the vial R _{1, is} more than 10%, ie H 1 / R 1 ≥ 0.1 is.

The positive effect of reducing the breakage rate increases with increasing Floor feed. It is "fully developed" when the relative ground indentation is more than Is 18%. This value is therefore preferred. This value for the Feeding has the further advantage that when cooling with heat intake through the Bottles of the vial freeze the solution at the jacket-floor transition begins. With further freezing, the still liquid solution will go up repressed. This ensures that the ice pressure on the Vial jacket and bottom sinks again considerably.

A deep indentation also has the Voneil that then during the Freezing forms an ice goblet open at the top. New growing ice then lay down inside the chalice. This reduces the pressure on the Vial bottom. This effect occurs when the relative ground intake is more than 25%. This whom is therefore most preferred.

On the other hand, too much ground pull-in causes problems. It will e.g. difficult with a relative ground indentation of more than 80% Empty the vial completely with a hypodermic syringe. Therefore is the relative bottom drawdown of the vials preferably less than 80%. It has It has also been shown that practical problems in handling and Manufacture of the vials can arise if the relative Ground intake is more than 50%. It also takes what is available Internal volume of the vial decreases too much.

In order to improve the stability and the thermal coupling in the bottom area in the vials shown, it is advantageous to make part of the bottom flat on the outer surface. This flat area should be (radially) outside in order to achieve the positive properties of the vials described above. Such an embodiment is shown in FIG. 2. In this vial, the vial bottom 3 is flat in an annular region 3 a with the radii R ₂ and R ₁ , the radius ratio R ₂ / R _{1 being} greater than 0.4 and less than 0.8.

A particularly advantageous embodiment of the vial with a partially planar bottom indentation results if the interior of the vial continues to be conical up to the vial jacket. This design is shown in Fig. 3, wherein R _{4 is} the radius of the conical area.

A particularly advantageous embodiment of the invention can be achieved if the container casing 1 has a taper towards the bottom 3, preferably a conical taper, as shown in FIGS. 4 and 5. R ₃ denotes the largest jacket radius (in FIGS. 1-3, it is equal to R ₁ ), R ₁ the smallest jacket radius and H3 the height of the taper.

This tapering of the bottom, ie the conical widening of the bottle shell on the inside, can promote the sliding of the ice plug upwards, thereby reducing the pressure on the bottom. This is particularly the case if the taper ratio, that is the ratio of the difference R ₃ -R ₁ to the amount of taper H ₃ , is more than 5%, ie (R 3rd -R 1 )/H 3rd ≥ 0.05 is.

Furthermore, the soil rejuvenation leads to the favorable property that the Icing of the solvent is preferred at the jacket-bottom transition of the Vial begins. As the ice front moves up or down liquid solution is displaced inside. This reduces the ice pressure on the Vial jacket and bottom. This effect occurs particularly clearly when the taper ratio is more than 12%, therefore this value prefers. Furthermore, the bottom rejuvenation when cooling with a liquid Cold coupling agents (outside) also lead to the favorable property that When the solution freezes, an ice goblet open on top forms on which Add new layers of ice inside. That has a favorable influence on the distribution of tension in the vial caused by the ice plug. This positive effect occurs particularly clearly when the taper ratio in according to a particularly preferred embodiment is more than 18%.

It was further found that the positive effect of the bottom rejuvenation also occurs if the taper is limited to the lower region 1 a of the vial, as shown in FIG. 5. The height of the bottom taper H ₃ should, however, be higher than the liquid level of the solution in the vial before the lyophilization.

In principle, the embodiment according to FIGS Bottom 3 has a planar annular region 3a as in the case of the figures Have 2/3.

Examples: Example 1:

The example describes a vial according to FIG. 1 from the "Fiolax®-brown" glass. The outside diameter of the vial is 22 mm, the wall thickness is 1 mm. The vial is made from a glass tube from Schott-Rohrglas. The inner radius of the vial is therefore R ₁ = 10 mm. It becomes a relative indentation of the bottle H 1 / R 1 = 0.3 adjusted, ie the floor retraction is absolutely 3 mm.

Example 2:

The example describes a conical vial according to FIG. 5 made of "Fiolax®-clear" glass (made from a glass tube from Schott-Rohrglas). The wall thickness of the vial is 1 mm, the outside diameter at the top 24 mm (R ₃ = 11 mm) and at the bottom 20 mm (R ₃ = 9 mm). The height H _{3 of} the vial is 15 mm. The taper is (R 3rd -R 1 )/H 3rd = 0.2.

The bottom indentation described for the glass vials shown can be produced by heating the vials after the rough shaping, at least in the bottom area, above the softening temperature of the glass and, for example, pressing them on a correspondingly shaped carbon or stainless steel mandrel. The shaping of the bottom indentation can be simplified if the shaping takes place with rotation of the vial or the mandrel, and if the carbon or stainless steel mandrel is coated with a lubricant or separating agent. Suitable lubricants or release agents are, for example, oil mixtures, graphite or calcium carbonate powder (CaCO ₃ ). This bottom formation can be associated with a thinning of the bottom of the vial in the bottom area. Surprisingly, this thinning of the soil in the vials according to the invention is not associated with a significant increase in the breakage rate when freezing.

The outside partially plane floor indentation 3 a according to FIGS. 2 and 3 can be manufacture when you have the vials after forming the bottom indent heated at least on the floor above the softening temperature of the glass (The bottom is preferably raised to a higher height after the bottom cone has been formed Temperature maintained and the bottom flattening subsequently carried out), and e.g. presses on a carbon or stainless steel plate. This can be simplified if you turn the vial or the plate and if the plate also is coated with a lubricant and release agent.

The continuation of the cone in the interior up to the bottom-jacket transition 3, e.g. achieve if you flatten before insert a blowgun into the vial and by blowing one Coolant (e.g. cold air) cools the inside of the floor so that the glass on the Inner surface is sufficiently tough and maintains its conical shape while the outer surface is still soft and can be flattened.

In the embodiments described so far, the invention is Round cross-sectional shape made of glass. However, he can can also be made of plastic.

The containers are preferably made of a plastic material, which is translucent or transparent so that the contents of the container are visible from the outside is inspectable.

The translucent plastic material used should preferably be used in a Wall thickness of 2 mm a light transmittance according to ASTM 1003 of> Have 90%. If the plastics used are not inherently those skilled in the art can be sufficiently translucent by adding known ones Additives increase transparency.

The plastic material for containers for lyophilization and storage of less oxygen-sensitive substances is selected from the group with a density <1.1 g / cm ³ , a water vapor permeability according to DIN 53122 with a layer thickness of 1 mm of <0.1 g / m ² · d and a water absorption according to ASTM D 570 of <0.05%. Plastic material with such a specification can be found in particular among the cycloolefin copolymers, such as, for example, under the trade names TOPAS® (all types) from Ticona, ZEONEX® from Nippon Zeon (all types, preferably ZEONEX®250 and ZEONEX®280) or APEL ® from Misui are commercially available. Cycloolefin copolymers with a water vapor permeability according to DIN 53122 of <0.03 g / m ² · d and a heat distortion temperature (HDTB / B (0.45 N / nm ² ) according to ISO 75 part 1 and 2 in the range between 50 ° C. are particularly preferred and 90 ° C, such as TOPAS®8007 with a glass transition temperature in the range of 60 ° C to 100 ° C.

The plastic material for containers for lyophilization and storage of more oxygen-sensitive substances is selected from the group with a density ≤ 1.4 g / cm ³ and an oxygen permeability according to DIN 53380 with a layer thickness of 100 µm of <50 cm ³ / m ² · d ·bar. Plastic material with such a specification is composed, for example, of polymers based on polyethylene terephthalate (PET), glycol-modified PET (PETG), oriented PET (O-PET) or polyethylene naphthalate (PEN).

The use of plastic for the manufacture of the invention Container also enables the production of Containers with a cross-sectional shape that differs from the circular shape. To improve the thermal conditions in the lyophilization process it is advantageous if the container according to the invention is level Has side surfaces that are able to make contact with the plan Side surfaces of each adjacent container body to kick. The A cross-sectional shape of such a container body can preferably be Triangle, a square or a hexagon. The cross-sectional shape is one Triangle, then at least two of the three sides are preferably the same Size. The preferred triangular cross-sectional shape is an isosceles one Triangle. With a square as a cross-sectional shape are advantageous at least two opposite sides parallel to each other educated. Such a cross-sectional shape can be a trapezoid Parallelogram, a rhombus, a rectangle and in particular a square his.

However, the preferred cross-sectional shape is a hexagon, each of which two opposite sides of equal length and parallel to each other are. A regular hexagon is most preferred.

The flat shape of the side surfaces of the container body and its Cross-sectional geometry make it possible to use a batch process lyophilizing batch of containers so in the lyophilization chamber to arrange that the available space is used optimally can be. The flat design of the side surfaces of the container casing together with the triangular, quadrangular or hexagonal Cross-sectional shape allow any container in a batch, provided it not exactly occupying a position on the outer areas of the footprint, so can be arranged so that it is in planar contact with each of its sides with the side surfaces of the container adjacent to it.

In addition to the optimal use of the footprint, this means that despite the generally lower thermal conductivity of plastics in comparison with glass, between the side surfaces of the container during the Heat transfer or compensation can take place during the lyophilization process, so that there is a more or less homogeneous in all containers of a batch Temperature distribution. The inevitable with round glass vials Dead volumes occurring between the containers, which act as heat insulators act between the walls of the individual containers, occur at the angular ones Containers.

Given a predetermined amount of good to be lyophilized and predetermined Space in a lyophilizer is therefore required when using the square container less time for lyophilization than when using conventional round vial. Then the good to be lyophilized can be distributed over a larger area at a given volume (plus the area for the dead volumes for round vials), can therefore a smaller fill level can be set than for round container bodies for the same volume, which then means the ratio of "active surface" to fill level in a container and therefore the efficiency of sublimation of the Ice from the active surface is enlarged. Conversely, one needed then a smaller footprint with the same filling level in the square container and thus smaller freeze drying systems than when using round ones Glass vials.

The angular container jacket cross-sectional shape is the subject of the older one Patent application 198 15 993.5 dated April 9, 1998, for further details Shape and plastic material of the container shows, hereby by reference to the older application for the disclosure content of the present Registration includes, as well as the achievable benefits.

Claims (10)

Containers for medical and fine chemical purposes for liquid and solid preparations, with a thin-walled transparent container jacket (1), an integrally molded discharge part (2) which can be closed with a conventional closure, and a floor (3) which is provided with a central feed (4), characterized by a tapering of the inside diameter of the container over the entire jacket height or the lower part thereof towards the bottom, and / or by a relative bottom indentation (4) of the container, described by the relative ratio of the height of the bottom indentation to the inside radius of the container, which is more than 10%, preferably more than 18% of the inner radius at the bottom of the container. Container according to claim 1, characterized in that the taper is conical. Container according to claim 1 or 2, characterized in that the relative tapering of the container base (3), predetermined by the ratio of the difference between the largest to the smallest casing radius to the height of the taper, is more than 5%, preferably more than 12% and most preferably more than 18%. Container according to one of claims 1 to 3, characterized in that the relative bottom indentation (4) is more than 25% of the inner radius at the bottom of the container. A container according to claim 4, characterized in that the relative bottom indentation of the container is less than 80% and preferably less than 50% of the inner radius at the bottom of the container. Container according to one of claims 1 to 5, characterized in that the container base has a flattened, annular area (3a) radially on the outside, in which the ratio of the inner radius to the outer radius is at least 40% and at most 80%. Container according to claim 6, characterized in that the inner surface of the bottom indentation (4) up to the container casing (1) is conically shaped. Container according to one of claims 1 to 7, characterized in that it has a height between 11 mm and 150 mm, a maximum outer diameter between 5 mm and 100 mm and a wall thickness in the jacket area of 0.2 mm to 3 mm. Container according to one of claims 1 to 8, characterized in that the container shell has flat side surfaces which are capable of planar contact with the side surfaces of an adjacent container shell and its cross section is that of a polygon. Use of the container according to one of claims 1 to 9 for the in-situ freeze drying of a liquid medical, biological or fine chemical preparation in the container.

Images